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Review question/objective
This review aims to examine the sensitivity and specificity of clinical stroke scores in distinguishing ischemic and hemorrhagic stroke subtypes in patients with acute stroke and determine the score best suited for use in resource poor settings.
The specific review question is: what is the sensitivity and specificity of clinical stroke scores in distinguishing ischemic from hemorrhagic stroke in patients with acute stroke, compared with non-contrast computed tomography?
Background
Stroke is a major cause of morbidity globally and is associated with up to 5.54 million deaths every year, two thirds of which occur in resource poor countries (RPC) . 1 The prevalence of stroke is reported to be higher in developed countries, probably due to a higher proportion of elderly individuals in their population.
However, it is possible that in resource poor settings, a lower prevalence is apparent due to higher case fatality.
The World Health Organization (WHO) defines stroke as a clinical syndrome of rapid onset of focal cerebral deficit lasting more than 24 hours (unless interrupted by surgery or death) with no apparent cause other than a vascular one. There are two main subtypes, ischemic or hemorrhagic. Of the two types, ischemic stroke is more common, occurring in up to 80% of patients. 2 Infarction takes several hours to occur because following occlusion of a cerebral artery, anastomotic channels from other arterial territories open up to restore perfusion to its territory. This allows for restoration of blood supply and reversal of the process, with subsequent reduction in neurological deficits, disability and other complications.
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Hemorrhagic stroke accounts for 15%-20% of all stroke cases and is associated with a higher mortality.
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There is bleeding directly into brain parenchyma due to damaged cerebral blood vessels. 5 Blood in the brain parenchyma causes disruption of neurons with localized cessation of function. The hemorrhage may expand and cause progression of neurological deficits. If large enough, it may cause a shift of intracranial contents and lead to rapid death. This type of stroke presents in a similar manner to ischemic stroke but has a more dramatic preceding clinical picture, usually headache, altered mental status, seizures, nausea and vomiting, and marked hypertension. However, none of these clinical features have been shown to reliably distinguish between the two sub-types of stroke. [6] [7] Clinically, stroke may evolve from a transient ischemic attack (TIA), progressing stroke, to a completed stroke, based on the duration and evolution of symptoms. 3 In TIA, symptoms resolve within 24 hours of onset while in progressing stroke, symptoms worsen, perhaps due to increasing volume of infarct or haemorrhage. In a completed stroke, the neurological deficits persist but do not progress. Neurological deficits can be elicited from the history and, if persistent, from neurological examination.
For optimal management of acute stroke, a distinction must be made between ischemic and hemorrhagic stroke since the therapy is different. 2 Ischemic stroke warrants institution of thrombolytic and/or antiplatelet therapy. Antiplatelet therapy has been shown to improve outcome and be cost effective even in RPC. [8] [9] In the management of acute hemorrhagic stroke, haemostatic therapy may be given but there is conflicting evidence on its benefit. 5 Inadvertent administration of anti-platelet or anti-thrombotic therapy in hemorrhagic stroke sub-type may aggravate the clinical course. Conversely, use of haemostatic therapy in ischemic stroke may promote vascular occlusion and worsen the infarction. Ideally, either thrombolytic or haemostatic therapy should be given soon after the onset of stroke in order to improve outcome.
Index tests and reference test
Non-contrast computed tomography (CT) scan is the most widely used brain imaging modality in patients with stroke and it reliably detects cerebral haemorrhage. It is the gold standard for distinguishing stroke sub-types. [10] [11] It is cheaper than magnetic resonance imaging (MRI), but it is still expensive and inaccessible in many RPCs.
To overcome the difficulties in accessing CT scan in the diagnosis of stroke and to enhance clinical bedside diagnosis, clinical stroke scores have been developed. The most commonly used ones include the Guy's hospital score (GHSS), 6 the Besson score, 12 the Greek stroke score 13 and the Siriraj stroke score (SSS).
14 In developing these scores, clinical variables that could potentially distinguish ischemia from haemorrhage in patients with acute stroke were used. A validation study was then performed to test the scores in patient populations other than the ones used in their development. The Greek score (GSS) was found to be 97% sensitive and 99% specific for the diagnosis of hemorrhagic stroke 13 while the Siriraj stroke score was 89.3% sensitive for haemorrhage and 93.2% sensitive for ischemia. 14 The Besson score had a positive predictive value of 100% in the diagnosis of ischemic stroke 12 while the Allen score is reported to have accurately diagnosed 90% of vascular lesions. 6 For the Siriraj score a score above 1 indicates hemorrhagic stroke while a score below -1 indicates ischemic stroke. A result between -1 and 1 indicates an equivocal result needing a CT scan. A score of below 4 for the Allen score indicates ischemic stroke while a score of above 24 indicates hemorrhagic stroke. For the Greek score, a score of 3 or less points to ischemic stroke while a score of 11 and above points to hemorrhagic stroke. A score of less than 1 for the Besson score diagnoses ischemic stroke with no cut off reported for hemorrhagic stroke .
Rationale for the review
CT scan is both expensive and largely unavailable in resource poor settings. There is also a paucity of specialists in the field of neurology with a large number of hospitals lacking a specialised stroke unit. Most patients with stroke in these parts of the world are inadequately diagnosed, resulting in poor outcomes.
These constraints highlight the need for clinical stroke scores to distinguish between the stroke sub types.
While these scores may not be sensitive enough to replace neuro-imaging, they are simple, cheap and practical, and do not require the presence of a specialist to administer and interpret. However, their true accuracy and value in the diagnosis of stroke remains unknown.
We intend to conduct a systematic review of available literature to examine the evidence on the accuracy of clinical stroke scores in distinguishing between stroke sub types. Further, we aim to compare the accuracies of the clinical scores in order to determine which score is best suited for use in RPCs. Thus, this will be a review of diagnostic test accuracy.
The main outcome measures will be sensitivity and specificity of the scores compared to CT scan as the reference standard. For the purpose of this review, sensitivity will be defined as the probability that a patient with the disease will have a positive test result while specificity will be defined as the probability that a patient without the disease will have a negative test result.
We searched PubMed, EMBASE, and the Cochrane and the Joanna Briggs Institute Libraries of systematic reviews in July 2012 and we did not identify any reviews either published or underway on this topic.
Inclusion criteria

Types of participants
This review will consider patients admitted to hospital with a diagnosis of acute stroke according to the WHO criteria. 2 There will be no age or sex limitation and we will consider participants from all ethnic backgrounds.
Types of interventions
This review will consider studies that evaluate the Siriraj, Allen (Guy's Hospital), Besson and Greek stroke scores with CT-Scan as the reference standard. Details on the calculation of test scores have been described previously. 6, [12] [13] [14] Studies that compare two or more of these scores simultaneously will also be included.
Types of outcomes
The review will consider studies that report on the sensitivity and specificity of stroke scores compared to CT scan diagnosis in distinguishing between stroke sub-types. Studies that do not report on sensitivity and specificity but have sufficient information to calculate these will also be considered for inclusion.
Types of studies
The review will consider studies of diagnostic test accuracy in which the index and reference tests are interpreted independently of one another on the same group of participants.
Search strategy
The search strategy aims to find both published and unpublished studies in English within the period 1983-2012 A three step strategy will be implemented. First, we will conduct an initial search of PubMed and EMBASE with analysis of text words in the title and abstract and of index terms used to describe the article.
A second search with all identified keywords and index terms across all included databases will then be done. Finally, the reference list of all included reports and articles will be searched for additional studies.
Databases to be searched include: PubMed, EMBASE, Cochrane central register of controlled trials (CENTRAL), Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Web of Science.
The search for unpublished studies will include: Virtual Health Library, System for Information for Grey
Literature in Europe (SIGLE), Scientific Electronic Library Online (SciELO), MedNar and ProQuest.
Initial keywords include: stroke, acute stroke, cerebrovascular accident, clinical stroke score, Siriraj stroke score, Guy's hospital stroke score, Allen score, Besson stroke score, Greek stroke score.
Assessment of methodological quality
Papers selected for review will be assessed by two independent reviewers for methodological validity prior to inclusion in the review using the QUality Assessment of Diagnostic Accuracy Studies (QUADAS) criteria 15 (Appendix I). Three other reviewers will randomly sample five or more included papers and assess them. Disagreements will be resolved through discussion.
Data collection
A modified Joanna Briggs Institute (JBI) data extraction form (Appendix II) will be used to collect details from included studies. Two authors will independently extract data from each study. Disagreements will be resolved through discussion. For each study, the following data will be obtained: author information, year of publication, study site, setting, study design, number and characteristics of patients (age, sex, ethnicity), data for each test will be taken directly from source papers. If this is not possible, they will be calculated from provided data.
Extracted data with consensus from both authors will then be entered in a separate form and transferred to a spreadsheet.
Data synthesis
We aim to generate 2 X 2 contingency tables with true positive (TP), false positive (FP), true negative (TN) and false negative (FN) cases. We will consider patients with ischemic stroke as false positives or true negatives when analysing the performance for detecting hemorrhagic stroke and count patients with hemorrhagic stroke as false positives or true negatives when analysing performance for detection of ischemic stroke. We will calculate sensitivity and specificity with 95% confidence intervals for each clinical score for each study as well as predictive values and likelihood ratios.
Meta-analysis will be undertaken using a bivariate mixed effects binomial regression model as described by Harbord et al. 16 Summary estimates for sensitivity, specificity, positive and negative predictive values, positive and negative likelihood ratios (LR) as well as diagnostic odds ratio, will be generated. Where meta-analysis is not possible, a narrative synthesis will be undertaken.
Heterogeneity will be assessed graphically using forest plots. For statistical heterogeneity we will use the quantity I 2 which describes the percentage of total variation across studies that is attributable to heterogeneity rather than chance. A value of 50% and above will be considered substantial heterogeneity.
Analysis will be performed on STATA v.11 (Stata Corp 
